AMPA Receptor Plasticity in the Nucleus Accumbens Mediates Withdrawal-Related Negative-Affective States

Total Page:16

File Type:pdf, Size:1020Kb

AMPA Receptor Plasticity in the Nucleus Accumbens Mediates Withdrawal-Related Negative-Affective States The Journal of Neuroscience, October 12, 2016 • 36(41):10505–10507 • 10505 Journal Club Editor’s Note: These short, critical reviews of recent papers in the Journal, written exclusively by graduate students or postdoctoral fellows, are intended to summarize the important findings of the paper and provide additional insight and commentary. For more information on the format and purpose of the Journal Club, please see http://www.jneurosci.org/misc/ifa_features.shtml. AMPA Receptor Plasticity in the Nucleus Accumbens Mediates Withdrawal-Related Negative-Affective States X Gabor Egervari Departments of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York 10029 Review of Russell et al. Addiction is a chronic, relapsing disorder neural plasticity underlying the emergence Naloxone induced a strong conditioned characterized by craving, compulsive drug of negative-affective states associated with place aversion in morphine-dependent rats, use, and loss of control over limiting drug withdrawal and compulsive drug seeking is and this effect was prevented by NBQX pre- intake (Koob and Volkow, 2010). The essential to guide the development of future treatment in the NAc shell (Russell et al., emergence of negative-affective states (e.g., therapeutic interventions targeting this crit- 2016, their Fig. 2B). The effects were specific dysphoria, anxiety, irritability) with chronic ical component of the addiction phenome- to the NAc shell, and none of the treatments drug use has been hypothesized to play a non (Koob and Mason, 2016). showed any effect in placebo-implanted crucial role in the transition from recre- Plasticity of glutamatergic synapses in rats. Somatic signs of withdrawal (e.g., irri- ational drug use (characterized by positive the NAc, a key area for integrating motiva- tability to touch, wet dog shakes) were not reinforcement) to full-blown addiction and tion, emotion, and reward, has been impli- affected by AMPA receptor blockade (Rus- compulsive drug seeking (driven mostly by cated as a critical component of long-term sell et al., 2016, their Fig. 3). These results negative reinforcement) This “dark side of neuronal maladaptations underlying addic- indicate that AMPA receptor function in the addiction” is thought to result from a com- tive behavior (Scofield et al., 2016). Chronic NAc shell might be selectively involved in pensatory decrease in the function of the morphine exposure, for example, potenti- the regulation of negative-affective but not normal reward neurocircuitry and persis- somatic signs of morphine withdrawal. tent recruitment of brain stress systems ates glutamatergic transmission at thalam- ostriatal projections by enhancing synaptic AMPA receptor function plays an im- (Koob, 2013). In addicted people, negative- portant role in both memory formation and insertion of AMPA receptors (Zhu et al., affective states associated with withdrawal forgetting (Migues et al., 2016). To confirm 2016). Further expanding this line of re- promote drug seeking and relapse; they that the observed effects were not due to search, a recent publication in The Journal of thus play a central role in the three-stage changes in associative learning or memory Neuroscience (Russell et al., 2016) investi- cycle of addictive behavior (binge/intoxica- impairments, Russell et al. (2016) measured gated the role of NAc AMPA receptor func- tion, withdrawal/negative affect, preoccu- the effects of naloxone and/or NBQX on pation/anticipation) (Koob, 2013). On the tion in regulating negative-affective states brain stimulation reward threshold in intra- circuit level, recreational drug use is medi- associated with withdrawal in morphine- cranial self-stimulation (ICSS), an operant ated by the nucleus accumbens (NAc), dependent rats. Animals were made de- paradigm in which rodents self-administer whereas compulsive drug-seeking is driven pendent by subcutaneous implantation of rewarding electrical stimulation via elec- by the dorsal striatum (Everitt and Robbins, morphine pellets, and withdrawal was trodes implanted in the brain (Carlezon and 2013). However, the molecular underpin- precipitated by subcutaneous delivery of Chartoff, 2007). Decreases and increases in nings of the transition to addiction remain ␮ naloxone, a potent -opioid receptor antag- ICSS threshold, defined as the amount largely elusive. A better understanding of onist. Withdrawal-induced negative-affec- of stimulation that is rewarding, indicate tive states were assessed by measuring heightened or attenuated reward sensitivity, conditioned place aversion. Selective inhibi- Received July 22, 2016; revised Aug. 24, 2016; accepted Aug. 26, 2016. respectively. Naloxone led to significant in- The authors declare no competing financial interests. tion of AMPA receptors was achieved by in- creases in ICSS thresholds, which were re- Correspondence should be addressed to Dr. Gabor Egervari, Depart- jecting antagonist NBQX into the NAc shell, versed by NBQX pretreatment in the NAc ments of Psychiatry and Neuroscience, Icahn School of Medicine at and behaviorally relevant doses were deter- shell (Russell et al., 2016, their Fig. 4D). This Mount Sinai, One Gustave L. Levy Place, New York, NY 10029. E-mail: mined based on observed decreases in [email protected]. is consistent with the hypothesis that NBQX DOI:10.1523/JNEUROSCI.2329-16.2016 AMPA-induced locomotion (Russell et al., exerts its inhibitory effects by blocking Copyright © 2016 the authors 0270-6474/16/3610505-03$15.00/0 2016, their Fig. 1). naloxone-induced negative-affective states 10506 • J. Neurosci., October 12, 2016 • 36(41):10505–10507 Egervari • Journal Club Figure 1. AMPA receptor plasticity in the NAc underlies withdrawal-related negative-affective states. A, Glutamatergic synapse in the NAc. B, Morphine dependence leads to increased surface expression of AMPA receptors, including GluA2-lacking receptors, resulting in enhanced glutamatergic transmission that underlies the expression of negative-affective states that promote relapse. C, Drug-induced molecular adaptations can be counteracted by using AMPA receptor antagonists, leading to a decrease in receptor function and negative-affective signs. rather than by disrupting associative learn- was specific to GluA1 and the NAc shell AMPA receptors are consistent with en- ing during conditioned place aversion. (Russell et al., 2016, their Fig. 6). hanced synaptic transmission, which is Two mechanisms by which neurotrans- The increase of GluA1 on the cell surface necessary for the expression of morphine mission at AMPA-receptor-containing syn- and in synaptosomal membranes, along withdrawal signs (Zhu et al., 2016). The re- apses can be regulated are changes in with the lack of change of GluA2, potentially sulting negative-affective states in turn mo- receptor levels and changes in subunit com- suggests an enrichment of GluA2-lacking tivate compulsive drug-seeking behavior. position. These mechanisms have been AMPA receptors in the NAc shell of mor- This model is consistent with previous liter- strongly implicated in neuronal maladapta- phine-dependent rats. Compared with ature showing that elevated NAc GluA1 lev- tions accompanying chronic drug adminis- GluA2-containing receptors, GluA2-lack- els result in aversive states (Todtenkopf et tration. For example, both total (Churchill ing AMPA receptors are permeable to Ca 2ϩ al., 2006), and emphasizes the role of gluta- et al., 1999) and surface (Boudreau and and exhibit higher single-channel conduc- matergic inputs to the NAc in promoting Wolf, 2005; Conrad et al., 2008) expression tance, faster kinetics, increased depolariza- drug seeking (LaLumiere and Kalivas, of the GluA1 AMPA receptor subunit were tion, and activation of Ca 2ϩ-dependent 2008). In line with this hypothesis, chronic increased in the NAc after chronic cocaine signaling cascades (Man, 2011). Changes in morphine exposure potentiated AMPAR administration. Withdrawal and reinstate- AMPA receptor subunit composition in transmission at thalamostriatal synapses via ment paradigms also result in increased glutamatergic synapses might therefore insertion of GluA2-lacking receptors (Zhu surface expression of GluA1 in the NAc contribute to altered AMPA receptor func- et al., 2016). This AMPAR potentiation was (Anderson et al., 2008). In addition, somatic tion in morphine-dependent and nalox- necessary for morphine withdrawal signs, signs of morphine withdrawal were de- one-treated rats, which in turn underlies which were suppressed by optogenetic de- creased by AMPA antagonists or by genetic negative-affective states associated with potentiation (Zhu et al., 2016). deletion of GluA1 (Rasmussen et al., 1996; morphine withdrawal. Indeed, Russell et al. The observations of Russell et al. (2016) Vekovischeva et al., 2001). Is a similar (2016) found that NASPM, a selective in- significantly advance our understanding of mechanism also at work in the regulation of hibitor of GluA2-lacking AMPA receptors, the molecular underpinnings of negative- affective components of withdrawal? had effects similar to those of NBQX: affective states associated with chronic To assess AMPA receptor subunit com- NASPM significantly attenuated naloxone- morphine use and withdrawal (Fig. 1). It re- position on the cell surface of NAc neurons, induced increases in brain stimulation mains to be seen whether similar mecha- Russell et al. (2016) used BS 3 to covalently thresholds in ICSS, although no such nisms apply to other addictive substances.
Recommended publications
  • MDMA and Sexual Behavior
    Note: This is a pre-copy-editing, author-produced PDF of an article accepted for publication in Substance Use & Misuse following peer review. The definitive publisher-authenticated version [McElrath K (2005) MDMA and sexual behavior: ecstasy users’ perceptions about sexuality and sexual risk, Substance Use & Misuse, 40:9, 1461-1477] is available online at http://www.informaworld.com/smpp/title~db=all~content=g714012467 MDMA and Sexual Behavior: Ecstasy Users’ Perceptions About Sexuality and Sexual Risk KAREN MCELRATH School of Sociology and Social Policy, Belfast, Ireland Published in Substance Use & Misuse,(2005) 40:9,1461—1477 This study examines the relationship between MDMA (Ecstasy), sexual behavior, and sexual risk taking. The sample consisted of 98 current and former users of MDMA. Several strategies were utilized to recruit respondents and data were collected through in-depth interviews during 1997 and 1998. The majority of respondents had used MDMA during the 6-month period prior to the interview and a large percentage had consumed the drug on 100 occasions or more. Most respondents reported feelings of emotional closeness while consuming MDMA but without the desire for penetrative sex. Others, however, reported that MDMA increased sexual arousal and some respondents (in particular gay and bisexual females) had used MDMA specifically for sexual enhancement. Sexual risk taking (e.g., having multiple partners, engaging in sex without a condom) was prevalent among respondents who did engage in sexual activity during MDMA episodes. Explanations for the findings are offered and implications for prevention/intervention are discussed. Keywords MDMA; ecstasy; sexual behavior Introduction Although a patent for 3,4-methylenedioxymethamphetamine (MDMA) was issued in 1914 (Shulgin, 1986), “recreational”a use of the drug did not surface until the 1970s and 1980s, and for the most part was restricted to selected regions in the U.S.
    [Show full text]
  • MDMA ('Ecstasy'): a Review of Its Harms and Classification Under the Misuse of Drugs Act 1971
    MDMA (‘ecstasy’): A REVIEW OF ITS HARMS AND CLASSIFICATION UNDER THE MISUSE OF DRUGS ACT 1971 Advisory Council on the Misuse of Drugs ACMD Advisory Council on the Misuse of Drugs 3rd Floor (SW), Seacole Building 2 Marsham Street London SW1P 4DF February 2008 Rt Hon Jacqui Smith MP Home Office 2 Marsham Street London SW1P 4DF Dear Home Secretary, The Advisory Council on the Misuse of Drugs (ACMD) recently considered that a review of MDMA (‘ecstasy’) would be timely as there is a much greater body of evidence regarding the harms and misuse of MDMA since the Council last provided its advice to Ministers in 1996. I have pleasure in enclosing the Council’s report. The use of MDMA is undoubtedly harmful. I would therefore like to emphasise that the Council continues to be concerned about the widespread use of MDMA; particularly among young people. Due to its prevalence of use, MDMA is a significant public health issue and we believe that criminal justice measures will only have limited effect. You will wish to note that the Council strongly advises the promulgation of public health messages. It is of vital importance that issues of classification do not detract from messages concerning public health. Forensic evidence shows that MDMA is by far the most commonly seized of the ‘ecstasy-like’ drugs. MDMA is presently generically classified in Class A under the Misuse of Drugs Act with other ‘ecstasy-like’ drugs. The ACMD has not extended this review to other compounds within the generic classification since their use is considerably less than that of MDMA.
    [Show full text]
  • Phencyclidine: an Update
    Phencyclidine: An Update U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES • Public Health Service • Alcohol, Drug Abuse and Mental Health Administration Phencyclidine: An Update Editor: Doris H. Clouet, Ph.D. Division of Preclinical Research National Institute on Drug Abuse and New York State Division of Substance Abuse Services NIDA Research Monograph 64 1986 DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Alcohol, Drug Abuse, and Mental Health Administratlon National Institute on Drug Abuse 5600 Fishers Lane Rockville, Maryland 20657 For sale by the Superintendent of Documents, U.S. Government Printing Office Washington, DC 20402 NIDA Research Monographs are prepared by the research divisions of the National lnstitute on Drug Abuse and published by its Office of Science The primary objective of the series is to provide critical reviews of research problem areas and techniques, the content of state-of-the-art conferences, and integrative research reviews. its dual publication emphasis is rapid and targeted dissemination to the scientific and professional community. Editorial Advisors MARTIN W. ADLER, Ph.D. SIDNEY COHEN, M.D. Temple University School of Medicine Los Angeles, California Philadelphia, Pennsylvania SYDNEY ARCHER, Ph.D. MARY L. JACOBSON Rensselaer Polytechnic lnstitute National Federation of Parents for Troy, New York Drug Free Youth RICHARD E. BELLEVILLE, Ph.D. Omaha, Nebraska NB Associates, Health Sciences Rockville, Maryland REESE T. JONES, M.D. KARST J. BESTEMAN Langley Porter Neuropsychiatric lnstitute Alcohol and Drug Problems Association San Francisco, California of North America Washington, D.C. DENISE KANDEL, Ph.D GILBERT J. BOTV N, Ph.D. College of Physicians and Surgeons of Cornell University Medical College Columbia University New York, New York New York, New York JOSEPH V.
    [Show full text]
  • Motor Delays in MDMA (Ecstasy) Exposed Infants Persist to 2 Years
    Neurotoxicology and Teratology 54 (2016) 22–28 Contents lists available at ScienceDirect Neurotoxicology and Teratology journal homepage: www.elsevier.com/locate/neutera Motor delays in MDMA (ecstasy) exposed infants persist to 2 years Lynn T. Singer a,⁎, Derek G. Moore b,MeeyoungO.Mina, Julia Goodwin b, John J.D. Turner b, Sarah Fulton a,AndrewC.Parrottc a Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44106, United States b The University of East London, Docklands Campus, University Way, London E16 2RD, United Kingdom c Swansea University, Singleton Park, Swansea, Wales SA2 8PP, United Kingdom, article info abstract Article history: Background: Recreational use of 3,4 methylenedioxymethamphetamine (ecstasy, MDMA) is increasing world- Received 29 July 2015 wide. Its use by pregnant women causes concern due to potentially harmful effects on the developing fetus. Received in revised form 5 January 2016 MDMA, an indirect monoaminergic agonist and reuptake inhibitor, affects the serotonin and dopamine systems. Accepted 20 January 2016 Preclinical studies of fetal exposure demonstrate effects on learning, motor behavior, and memory. In the first Available online 21 January 2016 human studies, we found prenatal MDMA exposure related to poorer motor development in the first year of life. In the present study we assessed the effects of prenatal exposure to MDMA on the trajectory of child devel- Keywords: opment through 2 years of age. We hypothesized that exposure would be associated with poorer mental and Behavior Cocaine motor outcomes. Alcohol Materials and Methods: The DAISY (Drugs and Infancy Study, 2003–2008) employed a prospective longitudinal Teratology cohort design to assess recreational drug use during pregnancy and child outcomes in the United Kingdom.
    [Show full text]
  • Recreational Drug Use: What’S the Harm?
    Your Employee and Family Assistance Program is a support service that can help you take the first step toward change. Recreational drug use: what’s the harm? Recreational drug use can be defined as the use of drugs strictly for pleasure, and quite often in social situations. Recreational users are not necessarily physically or psychologically dependent on drugs, however these users do run the risk of developing a dependency. There is considerable controversy surrounding the use of drugs, and opinions vary widely from those who think all drugs should be illegal, to those who advocate for the legalization of certain drugs. Even though it is illegal to use drugs such as marijuana, cocaine, LSD, ecstasy, and amphetamines, those who choose to use these substances can find them quite readily. And many—both young and old—believe there is little or no harm to using these drugs recreationally. Why use? Recreational drug users find that using drugs, from marijuana to cocaine, can help them: improve their mood, increase excitement and enjoyment, reduce inhibitions, become more relaxed, and achieve social acceptance among their peers. These benefits are generally reported to be immediate and short-term. The negative consequences of recreational drug use, on the other hand, tend to be delayed and longer term. Escalation Any recreational drug user risks escalation of their drug use, which in turn may develop into a drug dependency. Drug use and the problems associated with it may start off as limited or small, but gradually escalate to causing bigger problems in more areas of the user's life.
    [Show full text]
  • Substance Misuse: Result of Stress (Physical Or Emotional) Or Fatigue, Are Fungi Containing the Chemical Psilocybin
    Clinical sweating, numbness, confusion and difficulty Magic mushrooms concentrating. Longer term, flashbacks may In addition to their most common title, magic occur, during which the user re-experiences the mushrooms go by a wide range of names Module 1982 trip days, months or even years later, perhaps including Shrooms, Mushies, Magics, Liberties, following subsequent drug use but also as a Philosopher’s Stones, Amani and Agarics. They Substance misuse: result of stress (physical or emotional) or fatigue, are fungi containing the chemical psilocybin. which can trigger severe anxiety or paranoia. This pro-drug is converted in the body to hallucinogenics Tolerance can develop rapidly, and psychological psilocin, which has psychoactive properties. – though not physical – dependence can occur.1 Although there are over 180 psilocybin- From this CPD module you will learn: containing mushrooms found across the world, Substances the most commonly used in the UK is Psilocybe • What a hallucinogenic drug is, how they exert their effects and the This learning module will focus on magic semilanceata, a small, light brown mushroom risks associated with their use mushrooms and lysergic acid diethylamide, more known as the liberty cap. There is also the more • Detailed information about the two most used hallucinogens, magic commonly known as LSD, as these are the two potent Amanita muscaria, also known as the mushrooms and LSD hallucinogenic drugs widely used recreationally. fly agaric, which resemble the red and white It is worth noting that psychedelic drug use toadstools of fairy tales, though this contains • Some of the less commonly used psychedelic drugs appeared to increase during the COVID-19 additional psychoactive chemicals such as • Some relevant harm reduction measures for hallucinogenics pandemic, while use of substances such as ibotenic acid and muscimol which can cause ecstasy and nitrous oxide fell, in all likelihood delirium, drooling, dizziness and vomiting as well because these are more associated with highly as convulsions.
    [Show full text]
  • Signs & Symptoms of Dextromethorphan Exposure From
    Signs & Symptoms of Dextromethorphan Exposure from YouTube Michael Chary1, Emily H. Park2, Andrew McKenzie1, Julia Sun1, Alex F. Manini3, Nicholas Genes4* 1 Ichan School of Medicine at Mount Sinai, New York, New York, United States of America, 2 Rutgers New Jersey Medical School, Newark, New Jersey, United States of America, 3 Division of Medical Toxicology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America, 4 Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America Abstract Detailed data on the recreational use of drugs are difficult to obtain through traditional means, especially for substances like Dextromethorphan (DXM) which are available over-the-counter for medicinal purposes. In this study, we show that information provided by commenters on YouTube is useful for uncovering the toxicologic effects of DXM. Using methods of computational linguistics, we were able to recreate many of the clinically described signs and symptoms of DXM ingestion at various doses, using information extracted from YouTube comments. Our study shows how social networks can enhance our understanding of recreational drug effects. Citation: Chary M, Park EH, McKenzie A, Sun J, Manini AF, et al. (2014) Signs & Symptoms of Dextromethorphan Exposure from YouTube. PLoS ONE 9(2): e82452. doi:10.1371/journal.pone.0082452 Editor: Renaud Lambiotte, University of Namur, Belgium Received May 28, 2013; Accepted October 23, 2013; Published February 12, 2014 Copyright: ß 2014 Chary et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
    [Show full text]
  • Mental Health Effects of Recreational Drugs and Alcohol Understanding
    Understanding the mental health effects of recreational drugs and alcohol understanding mental health effects of recreational drugs and alcohol 1 Understanding the mental health effects of recreational drugs and alcohol This booklet is for anyone who wants to know more about the mental health effects of recreational drugs and alcohol. It explains how drugs and alcohol affect mental health, and what might happen if you use recreational drugs and have a mental health problem. It also provides information on what support is available and guidance for friends and family. Contents What are recreational drugs and alcohol? 4 How can recreational drugs affect mental health? 5 What types of drugs are there? 8 What effect could different drugs have? 11 Can recreational drugs and medication affect each other? 32 What support is available? 36 What help is available if I have a dual diagnosis? 38 How can family and friends help? 42 Useful contacts 45 3 Understanding the mental health effects of recreational drugs and alcohol What are recreational drugs and alcohol? Drugs are substances people take: • to give themselves a pleasurable experience • to help them feel better if they are having a bad time • because their friends are using them • to see what it feels like. They include alcohol, tobacco (nicotine), substances such as cannabis, heroin, cocaine and ecstasy, and some prescribed medicines. All my experiences with recreational drug use started due to social influences, of wanting to 'fit in'. Recreational drugs may be: • legal – such as nicotine and alcohol • illegal – this means it is against the law to have them or supply them to other people; most recreational drugs are illegal • controlled – these are drugs used in medicine, such as benzodiazepines; it is legal to take controlled drugs if a doctor has given you a prescription for them but it is illegal to have them if not; it is also illegal to give or sell controlled drugs to anyone else.
    [Show full text]
  • Subacute Degeneration of the Spinal Cord Due to Nitrous Oxide Inhalation
    Journal of Neurology (2018) 265:1089–1095 https://doi.org/10.1007/s00415-018-8801-3 ORIGINAL COMMUNICATION No laughing matter: subacute degeneration of the spinal cord due to nitrous oxide inhalation Stephen Keddie1,2 · Ashok Adams1 · Andrew R. C. Kelso1,4 · Benjamin Turner1 · Klaus Schmierer1,4 · Sharmilee Gnanapavan1,4 · Andrea Malaspina1,4 · Gavin Giovannoni1,4 · Ian Basnett1 · Alastair J. Noyce1,3,4,5 Received: 28 January 2018 / Revised: 13 February 2018 / Accepted: 14 February 2018 / Published online: 3 March 2018 © The Author(s) 2018. This article is an open access publication Abstract Background Whilst the dangers of ‘legal highs’ have been widely publicised in the media, very few cases of the neurological syndrome associated with the inhalation of nitrous oxide (N­ 2O) have been reported. Here we set out to raise awareness of subacute degeneration of the spinal cord arising from recreational ­N2O use so that formal surveillance programs and public health interventions can be designed. Methods Case series documenting the clinical and investigational features of ten consecutive cases of subacute degeneration of the spinal cord presenting to a hospital with a tertiary neurosciences service in East London. Results Sensory disturbance in the lower (± upper) limbs was the commonest presenting feature, along with gait abnormali- ties and sensory ataxia. MRI imaging of the spine showed the characteristic features of dorsal column hyperintensity on ­T2 weighted sequences. Serum ­B12 levels may be normal because subacute degeneration of the spinal cord in this situation is triggered by functional rather than absolute ­B12 defciency. Discussion A high index of suspicion is required to prompt appropriate investigation, make the diagnosis and commence treatment early.
    [Show full text]
  • Acute Toxic Effects of Club Drugs
    Club drugs p. 1 © Journal of Psychoactive Drugs Vol. 36 (1), September 2004, 303-313 Acute Toxic Effects of Club Drugs Robert S. Gable, J.D., Ph.D.* Abstract—This paper summarizes the short-term physiological toxicity and the adverse behavioral effects of four substances (GHB, ketamine, MDMA, Rohypnol®)) that have been used at late-night dance clubs. The two primary data sources were case studies of human fatalities and experimental studies with laboratory animals. A “safety ratio” was calculated for each substance based on its estimated lethal dose and its customary recreational dose. GHB (gamma-hydroxybutyrate) appears to be the most physiologically toxic; Rohypnol® (flunitrazepam) appears to be the least physiologically toxic. The single most risk-producing behavior of club drug users is combining psychoactive substances, usually involving alcohol. Hazardous drug-use sequelae such as accidents, aggressive behavior, and addiction were not factored into the safety ratio estimates. *Professor of Psychology, School of Behavioral and Organizational Sciences, Claremont Graduate University, Claremont, CA. Please address correspondence to Robert Gable, 2738 Fulton Street, Berkeley, CA 94705, or to [email protected]. Club drugs p. 2 In 1999, the National Institute on Drug Abuse launched its Club Drug Initiative in order to respond to dramatic increases in the use of GHB, ketamine, MDMA, and Rohypnol® (flunitrazepam). The initiative involved a media campaign and a 40% increase (to $54 million) for club drug research (Zickler, 2000). In February 2000, the Drug Enforcement Administration, in response to a Congressional mandate (Public Law 106-172), established a special Dangerous Drugs Unit to assess the abuse of and trafficking in designer and club drugs associated with sexual assault (DEA 2000).
    [Show full text]
  • Gastrointestinal, Hepatic and Biliary Sequelae of Frequent Ketamine Use: a Prospective Observational Study
    Gastrointestinal, hepatic and biliary sequelae of frequent ketamine use: a prospective observational study Reference number BDF 140031 Final Research Report Dr. Seto Wai Kay Walter Clinical Associate Professor Department of Medicine The University of Hong Kong 1 Background Recreational use1 of inhalational ketamine is emerging as a major global social and health issue [1, 2]. While ketamine, a N-methyl D-aspartate receptor antagonist, has medical uses in anesthesia and chronic pain control, its highly addictive nature has led to a massive increase in recreational consumption worldwide. Due to the ease of production and low cost, the non-medical use of ketamine is especially increasing in East and South East Asia, with its lifetime prevalence in the general population ranging from 0.3% to 2.0% [United Nations 3], comprising up to 39.7% of total recreational drug users in these regions [4]. The self-reported use of recreational ketamine in Western countries, including the United Kingdom, Australia and Canada, is also increasing [5, 6]. From 2008 to 2014, law enforcement seizures of ketamine worldwide has increased by more than threefold [3]. Long-term heavy use of ketamine is associated with different medical problems, including cognitive impairment and psychological issues [7]. Inhalation of ketamine could result in hallucinations, out-of-the-body experiences and psychological dissociation. One of the well-known side effects of ketamine is bladder dysfunction, which is seen in one- quarter of chronic ketamine users [8]. Damage to the urological system is also well- documented, with many ketamine users developing a large variety of urinary problems, ranging from lower urinary tract symptoms and bladder incontinence to hydronephrosis, renal impairment and papillary necrosis [8, 9].
    [Show full text]
  • An Update on Licit and Illicit Ketamine Use
    Substance Abuse and Rehabilitation Dovepress open access to scientific and medical research Open Access Full Text Article REVIEW To use or not to use: an update on licit and illicit ketamine use Jih-Heng Li1 Abstract: Ketamine, a derivative of phencyclidine that was developed in the 1960s, is an Balasingam Vicknasingam2 anesthetic and analgesic with hallucinogenic effects. In this paper, the pharmacological and Yuet-wah Cheung3 toxicological effects of ketamine are briefly reviewed. Ketamine possesses a wide safety margin Wang Zhou4 but such a therapeutic benefit is somewhat offset by its emergence phenomenon (mind-body Adhi Wibowo Nurhidayat5 dissociation and delirium) and hallucinogenic effects. The increasing abuse of ketamine, initially Don C Des Jarlais6 predominantly in recreational scenes to experience a “k-hole” and other hallucinatory effects but more recently also as a drug abused during the workday or at home, has further pushed Richard Schottenfeld7 governments to confine its usage in many countries. Recently, urinary tract dysfunction has 1 College of Pharmacy, Kaohsiung been associated with long-term ketamine use. In some long-term ketamine users, such damage Medical University, Kaohsiung, Taiwan; 2National Centre for Drug can be irreversible and could result in renal failure and dialysis. Although ketamine has not yet Research, Universiti Sains Malaysia, been scheduled in the United Nations Conventions, previous studies using different assessment 3 Malaysia; Department of Sociology, parameters to score the overall harms of drugs indicated that ketamine may cause more harm The Chinese University of Hong Kong, Hong Kong, China; 4Wuhan than some of the United Nations scheduled drugs. Some countries in Southeast and East Asia Center for Disease Control and have reported an escalating situation of ketamine abuse.
    [Show full text]